Delivery Order SPE2DB20D2104-SPE2DB22FR92E
Award Date
2/24/22
Potential Completion Date
2/25/22
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lubiprostone 24 MCG Capsule 60s, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The ceiling value of the delivery order is $2,372.99, with a firm fixed price. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsule 60S, a pharmaceutical product. The $3,999.85 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 5, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lubiprostone 24 MCG Capsules. The $2,891.20 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 25, 2021. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC enables the DLA to efficiently...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 24 MCG Capsule 60S. The contract is a firm fixed price delivery order with a ceiling value of $2,042.65 and has a performance period through November 21, 2022. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 MCG Capsules. The $1,358.73 firm fixed-price contract has an ultimate completion date of October 19, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lubiprostone 8 mcg capsules. The $1,297.56 firm-fixed-price contract has a completion date of September 9, 2022 and was awarded on September 8, 2022. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of LUBIPROSTONE 24 MCG CAPSULE 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order contract valued at $6,163.35. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that serves as a key supplier to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,099.57 firm fixed-price delivery order contract is for the supply of Lubiprostone 8 MCG Capsules. The contract has an ultimate completion date of January 19, 2023. AmerisourceBergen is the prime contractor and there is no set-aside designation, indicating open competition. This award is associated with a larger...
This federal contract award, valued at $1,827.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 60 capsules of the pharmaceutical product Lubiprostone 24 MCG. The contract is a Firm Fixed Price Delivery Order with a completion date of May 8, 2023. This contract award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several...